Subscribe To
Revolution medicines to present new clinical data at major oncology conferences and host investor webcast
Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESM...
October 4, 2023, 8:05 pm
Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for...
October 4, 2023, 4:05 pm
Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...
October 4, 2023, 4:00 pm
Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...
October 4, 2023, 11:30 am
Foghorn therapeutics to present clinical and pre-clinical data from multiple programs across its diverse pipeline at aacr-nci-eortc international conference
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a ne...
October 4, 2023, 8:00 am
Karuna therapeutics to present data from the emergent program evaluating karxt in schizophrenia at the 36th european college of neuropsychopharmacology (ecnp) congress
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative...
October 4, 2023, 6:30 am
Biotechnology breakthroughs: 3 biotech stocks that could make early investors rich
In the landscape of modern medicine, a trio of biotech giants may rewrite the rules of healthcare. In a world where precision and personalization have...
October 3, 2023, 5:00 pm
Novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
Vas Narasimhan, CEO at Novartis, discusses the company's 100% spin off of Sandoz, its generic and biosimilar medicines business, and what the deal mea...
October 3, 2023, 11:26 am
Editas medicine: ruby gems, sparkling catalysts in sickle cell arena
Editas Medicine's reduced R&D costs and strong cash position provide operational comfort but necessitate future capital, especially amid looming compe...
October 3, 2023, 2:59 am
Astrazeneca to pay $425 mln to settle nexium, prilosec litigation in us
British drugmaker AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations related to acid-reflux ...
October 3, 2023, 2:16 am
Drugmakers sign on to negotiate medicare prices under protest
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, includin...
October 2, 2023, 1:02 pm
Clade therapeutics announces the acquisition of gadeta b.v.
Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform technology,– g/d TCR ca...
October 2, 2023, 12:30 pm
Moonshot medicine: 3 stocks to buy to bet on long-shot drugs
Clinical trials are a difficult and grueling process for companies. The FDA and other regulatory agencies require the highest possible standards in or...
September 30, 2023, 3:00 pm
Why editas medicine stock is soaring today
Stifel upgraded Editas medicine stock from hold to buy and raised the price target from $9 to $17. The ...
September 29, 2023, 11:21 am
Why is opgen (opgn) stock up 115% today?
OpGen (NASDAQ: OPGN ) stock is on the rise Friday after the precision medicine company withdrew a shar...
September 29, 2023, 8:22 am
Organogenesis applauds withdrawal of local coverage determinations by novitas, first coast service options and cgs
Thanks Stakeholders who Advocated for Patients CANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leadin...
September 28, 2023, 1:15 pm
Nektar (nktr), cellular biomedicine join for lung cancer studies
Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination wit...
September 28, 2023, 9:01 am
Aclaris therapeutics: the many lives of this biopharmaceutical developer
Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...
September 28, 2023, 7:18 am
Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating tr...
September 27, 2023, 9:01 am
Prime medicine: not yet primed for retail investment
Prime medicine is developing prime editing, a highly precise gene editing technology that offers advant...
September 27, 2023, 8:49 am